Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aqua-Spark is a global investment fund and holding company focused on building and supporting a portfolio of companies that deliver innovative, sustainable solutions across the aquaculture value chain. They do not develop therapeutics themselves, but invest in companies—some of which are in biotechnology or health—focused on sustainable feed, health, and other aquaculture technologies. Recent investments include mycoprotein (eniferBio), digital aquaculture tech (e.g., eFishery), and salmon byproduct valorization (Hofseth Biocare).
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Aqua-Spark.